Phase Forward to Present at the Raymond James 31st Annual Institutional Investors Conference

Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its chairman and chief executive officer, Bob Weiler, and senior vice president and chief financial officer, Chris Menard, will present at the Raymond James 31^st Annual Institutional Investors Conference at the JW Marriott Grande Lakes Hotel in Orlando, Florida.

The Phase Forward presentation is scheduled for Tuesday, March 9, 2010 at 4:35 p.m. ET. The presentation will be webcast live and will be available by visiting the Investors section of the company’s website at www.phaseforward.com. The webcast will be archived on the company’s website for 30 days after the conference ends.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, SGS, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.